Neogen Corporation (NEOG) Stock Forecasts

NEOG reported Q3 revenue of $222.8M, beating estimates by 7%, and adjusted EPS of $0.08, beating by 50%. Adjusted EBITDA was $41.6M, an 18.7% margin. The company raised FY revenue guidance to $887.5M and EBITDA to $182M. Management highlighted commercial execution gains, innovation investments, and operational efficiency improvements.

Neogen reported Q1 fiscal 2027 revenue of $222.8M, up 6.5%, with Food Safety and Animal Safety segments growing 7.4% and 4.2%, respectively. Gross margin improved to 47.4%. Adjusted net income rose to $17.5M. The company raised its fiscal 2027 revenue guidance to $885M-$890M and adjusted EBITDA guidance to $181M-$183M.

Neogen (NEOG) received an FDA warning over a contaminated veterinary product. The company's response and any follow-up actions will be key for investors to monitor. Additionally, investors should review the company's management structure and compensation packages.

Neogen Corporation reported Q1 FY2027 revenue of $222.8 million, up 6.5%, and adjusted EPS of $0.08, exceeding estimates. GAAP EPS was negative at $0.05. Shares initially rose 8% after hours. The company raised annual guidance, citing higher margins and positive free cash flow.

Neogen reported Q1 revenue of $222.8M, up 8.1% core, with Food Safety and Animal Safety segments driving growth. Management raised fiscal 2027 guidance to $885M-$890M sales and adjusted EBITDA of $181M-$183M, citing strong demand and operational improvements. The company plans to use genomics divestiture proceeds for debt reduction, aiming for net leverage below 3x.

Neogen Corporation (NEOG) outlined its growth strategy at its 2026 Investor Day, targeting high-single-digit to low-double-digit revenue growth, high-50% adjusted gross margin, and 30% adjusted EBITDA margin by FY2031. The company plans to increase R&D investment by 50% in FY2027, aiming for $100M in incremental revenue from new products by FY2031. Neogen also highlighted its data platform, Neogen Analytics, as a key driver of recurring revenue and customer retention.